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Mycobacterium bovis is the causative agent of bovine tuberculosis, a disease that is increasing in incidence in
United Kingdom cattle herds. In addition to increasing economic losses, the rise in bovine tuberculosis poses
a human health risk. There is an urgent requirement for effective strategies for disease eradication; this will
likely involve vaccination in conjunction with current test and slaughter policies. A policy involving vaccination
would require an accurate diagnosis ofM. bovis-infected animals and the potential to distinguish these animals
from vaccinates. Currently used diagnostic tests, the skin test and gamma interferon (IFN-) blood test, have
a sensitivity of up to 95%. A further complication is that M. bovis BCG-vaccinated animals are also scored
positive by these tests. We tested the hypothesis that the quantification of IFN--producing lymphocytes by flow
cytometric analysis of intracellular IFN- expression would provide a more accurate discrimination of M.
bovis-infected animals from BCG vaccinates. Significant numbers of IFN--expressing CD4 T cells were
detected following culture of heparinized blood from M. bovis-infected animals, but not from BCG vaccinates,
with purified protein derived fromM. bovis (PPD-B) or live mycobacteria. Only 1 of 17 BCG-vaccinated animals
had a significant number of CD4 T lymphocytes expressing IFN-, compared with 21/22 M. bovis-infected
animals. This assay could allow an accurate diagnosis of M. bovis and allow the discrimination of BCG-
vaccinated cattle from infected cattle.
The increase in incidence in bovine tuberculosis, caused by
infection with Mycobacterium bovis, in developed countries
such as the United Kingdom, New Zealand, and the United
States poses significant economic problems and increasing
risks to human health. Despite the continued use of the skin
test and slaughter policies in the United Kingdom, the inci-
dence of bovine tuberculosis (TB) in United Kingdom cattle
herds is now increasing rapidly. There is now clearly a require-
ment for improved diagnostic tests and/or vaccination of cattle
to halt the spread of this disease and thus reduce economic
losses and risks to human health. Currently, the two most
widely used diagnostic tests for tuberculosis in cattle are based
on the detection of established cell-mediated immune responses:
(i) the delayed-type hypersensitivity (DTH) response, detected
by the comparative tuberculin skin test (25), and (ii) the in
vitro synthesis of gamma interferon (IFN-) by whole blood
cultured with mycobacterial antigens (purified protein deriva-
tive [PPD]), which can be subsequently detected by the Bovigam
enzyme-linked immunosorbent assay (ELISA) (41). However,
it is well documented that both diagnostic techniques are only
partially successful in distinguishing infected cattle from
healthy, uninfected animals, with reported sensitivities ranging
from 68 to 95% for the skin test (25). Several factors also affect
the sensitivity of the IFN- test; these factors may include the
proximity of blood sampling to the time of skin test and
the time between blood sampling and assay setup (11, 30, 31).
However, major factors underlying the lack of sensitivity of
both diagnostic tests is prior exposure of cattle to other myco-
bacteria present within the environment that share common
antigens with M. bovis and nonspecific responses possibly due
to NK cells in young animals (13). Incorrect diagnosis may
cause significant problems; for example, where false positives
exist, the movement restrictions that are placed on farms with
herd breakdowns have significant negative economic impacts
on those affected farms. Infected cattle that are “missed” by
the skin test (false negatives) are a possible source of cattle-
to-cattle transmission of M. bovis.
To date, there are no commercial vaccines available for
tuberculosis in cattle. The human vaccine strain M. bovis BCG
produces significant protection (2, 3) but has been shown to
have variable efficacy in cattle, as in humans. This variation,
like the failure of diagnostic tests, has been attributed to the
effects of environmental sensitization to other mycobacterial
species. More recently, alternative vaccination strategies such
as neonatal vaccination (15, 22, 36) and heterologous prime-
boost vaccination (7, 23, 24, 38) have significantly improved the
efficacy of BCG such that it is now being considered for addi-
tional trials in humans and cattle. However, BCG-vaccinated
individuals test positive by both the skin test and the standard
IFN- test, and therefore, there is an important requirement
for the development of quick, sensitive diagnostic tests that can
distinguish vaccinated subjects from those that are infected
with virulent mycobacteria. Discrimination of BCG-vaccinated
cattle from M. bovis-infected cattle has been achieved through
the use of antigens such as ESAT-6 and CFP-10 (35), which are
present in virulent M. bovis strains but are absent from BCG.
Reactivity to ESAT-6 and/or CFP-10 was shown to correlate
with disease severity and could be used to distinguish protected
BCG vaccinates from M. bovis-infected animals (4, 37). How-
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ever, reactivity to these antigens is not observed in all M.
bovis-infected animals (29) and is significantly affected by prior
sensitization of cattle to environmental mycobacteria (14).
Thus, more specific antigens or more sensitive assay systems
are required for the accurate diagnosis of bovine TB and the
distinction of vaccinated individuals.
It is well documented that cytokine secretion, and IFN-
production in particular, is associated with protective immune
responses to Mycobacterium tuberculosis and M. bovis infec-
tions (18, 27). The requirement for IFN- was elegantly dem-
onstrated in IFN- knockout mice, which are extremely sus-
ceptible to mycobacterial infections and may even succumb to
fatal BCG infections (5, 8). Classically, IFN- has been de-
tected in infected animals, or humans, by ELISA measurement
of IFN- secreted in vitro following stimulation of blood or
peripheral blood mononuclear cells (PBMC) with mycobac-
terial antigens. The enzyme-linked immunospot (ELISPOT)
technique, which detects numbers of IFN--secreting cells, al-
lows the estimation of the precursor frequency of antigen-
specific IFN--secreting cells and has been suggested to accu-
rately differentiate M. tuberculosis- or M. bovis-infected
individuals from BCG-vaccinated humans (24, 37). More re-
cently, the development of cytokine flow cytometry (CFC) has
proven to be an extremely sensitive methodology for assaying
numbers of antigen-specific cytokine-expressing cells in PBMC
and whole blood (32, 39). These assays, where cells can be
induced to produce IFN- in response to antigen in vitro, are
potentially useful indicators of immune status. CFC has been
compared with alternative measures of T-cell immunity such as
cell proliferation assays, cytotoxic-T-lymphocyte assays, major
histocompatibility complex oligomer assays, and ELISPOT (6,
17, 19, 28), and there is relatively good correlation with each
technique.
In this study, we describe the development of bovine CFC for
the detection of mycobacterial antigen-specific IFN--secreting
cells. We hypothesized that M. bovis-infected animals would have
higher numbers of persisting circulating antigen-specific cells than
BCG-vaccinated or control animals. The expression of IFN- by
CD4, CD8, and WC1  T lymphocytes was measured in cattle
experimentally infected with M. bovis or vaccinated with BCG.
We demonstrated that cells from infected cattle consistently
showed higher numbers of CD4 T cells expressing IFN- than
BCG-vaccinated cattle, which were detectable by CFC following
in vitro stimulation of whole blood for 24 h with PPD or BCG.
These data suggest that this method could accurately diagnose M.
bovis-infected cattle in the field.
FIG. 1. Detection of intracytoplasmic IFN- in whole-blood cultures. Blood taken from M. bovis-infected animals 12 weeks postinfection was
cultured in vitro for 24 h with PBS (a), PPD-B (b), BCG (c), or M. bovis (d). Expression of intracellular IFN- within CD4 T cells was examined
by flow cytometry. Percentages of cells in each quadrant are illustrated. One representative animal of three is shown.
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MATERIALS AND METHODS
Inoculation of animals with BCG or M. bovis. Cattle were British Holstein-
Friesian calves (Bos taurus) bred at the Institute for Animal Health. The Institute
for Animal Health herd has been confirmed to be free of bovine TB for more
than 10 years.
Calf groups were (i) noninoculated control animals, (ii) calves inoculated
subcutaneously with 1 106 CFU BCG Pasteur as previously described (15), (iii)
calves inoculated intranasally with 1 104 CFU virulent M. bovis AF2122/97 (15)
(experiment 1), and (iv) calves inoculated intratracheally with 5  103 CFU M.
bovis (37) (experiment 2).
Animals were vaccinated with BCG at approximately 1 month of age. For
challenge experiments, animals were between 4 and 9 months old at the time of
inoculation. Comparisons were made using age-matched animals either vacci-
nated with BCG or infected with M. bovis. The control and immunized animals
were housed separately in standard animal accommodations, and the infected
animals were kept in high-security (Advisory Committee on Dangerous Patho-
gens category 3) units. Animals were sampled at various time points postinfec-
tion, as indicated in Results. The experiments were approved by the local ethics
committee according to national United Kingdom guidelines.
Antigens and mycobacteria. Purified protein derivative from M. bovis (PPD-B)
was obtained from the Tuberculin Production Unit at the Veterinary Laborato-
ries Agency, Weybridge, United Kingdom. BCG Pasteur was diluted from a
previously titrated frozen (70°C) stock grown in Middlebrook 7H9 broth con-
taining 10% albumin-dextrose-catalase supplement (12). Numbers of CFU were
determined on 7H10 agar plates. M. bovis strain AF2122/97 (9), grown in 7H9
broth for 7 days, was frozen at 70°C. A 1-ml aliquot was thawed and cultured
in 10 ml of 7H9 broth for 7 days at 37°C to produce log-phase cells. The optical
density at 600 nm was measured, and the culture was diluted in 7H9 broth to give
an estimated 5  103 CFU per ml based on a comparison with a previously
established standard curve. The number of CFU was determined on 7H11 agar
containing 10% oleic acid-albumin-dextrose-catalase supplement and 4.16 g
pyruvate per liter.
Collection of blood. Blood samples were taken by venepuncture at the indi-
cated times postvaccination or postchallenge. Sodium heparin (10 units per ml;
Leo Laboratories, Princes Risborough, United Kingdom) was used as an anti-
coagulant. Cultures were set up within 2 h of collection.
CFC. The CFC protocol employed was a modification of that described pre-
viously by Suni et al. (32). Whole-blood samples were incubated for 20 to 24 h at
37°C with 2.5  105 CFU M. bovis or 2.5  106 CFU BCG per ml of blood, 20
g/ml PPD-B, or an appropriate volume of phosphate-buffered saline (PBS) as
a control. The numbers of CFU of BCG and M. bovis added per ml blood were
calculated to give CFU/cell ratios of approximately 10:1 and 1:1, respectively.
These CFU/cell ratios were previously determined to be optimal in this labora-
tory. For the final 4 h of the incubation period, 10 g/ml brefeldin A was added.
Following this, red blood cells were lysed for 30 min with FACSlyse solution (1
volume 10 FACSlyse mixed with 8 volumes of water and added to 1 volume of
blood; Becton Dickinson, San Jose, CA). Following two washes in PBS, the cells
were permeabilized for 20 min in FACS permeabilizing solution (1 ml per 1 ml
blood; Becton Dickinson). After a further two washes in PBS, cells were resus-
pended in PBS–1% bovine serum albumin–0.1% sodium azide. Aliquots of the
cell suspensions were transferred to microtiter plates and stained using a stan-
dard indirect immunofluorescence protocol. The following mouse anti-bovine
monoclonal antibodies (mAbs) were used: CD4, CC30 (immunoglobulin G1
[IgG1]) or CC8 (IgG2a), CD8, CC63 (IgG2a), WC1 (26), CC39 (IgG1) or CC15
(IgG2a), IFN-, CC302 (IgG1) (Serotec, Kidlington, United Kingdom), CC302-
fluorescein isothiocyanate (Serotec), or 6H5 (IgG2a) (40). In some instances,
mAbs were directly coupled to allophycocyanin using a Phycolink APC conju-
gation kit (ProZyme, San Leandro, CA). Isotype- and concentration-matched
controls were mouse anti-avian mAb as previously described (13). Where non-
conjugated mAbs were used, specific binding was detected with goat anti-mouse
IgG1 phycoerythrin and goat anti-mouse IgG2a fluorescein isothiocyanate
(Southern Biotech). The cells were assayed using a flow cytometer (FACSCalibur;
Becton Dickinson), and the data were analyzed using FCS Express (De Novo
Software, Ontario, Canada). The mononuclear cells were identified by light-
scattering properties, and the percentages of CD4, CD8, or WC1 cells that
produced IFN- were calculated.
RESULTS
Detection of intracytoplasmic IFN- in response toM. bovis,
BCG, and PPD-B. Blood from M. bovis-infected animals was
cultured for 24 h with M. bovis, BCG, or PPD-B, and the
expression of IFN- within CD4 T cells was examined (Fig.
1). Each of these antigens stimulated significant increases in
IFN--expressing cells compared to the control (Fig. 1a). The
in vitro responses to PPD (Fig. 1b) (P  0.05), BCG (Fig. 1c)
(P  0.05), and M. bovis (Fig. 1d) (P  0.05) varied slightly in
terms of the number of responsive cells and the intensity of
staining. For further studies, PPD-B and BCG were utilized in
preference to M. bovis to minimize the handling of virulent
mycobacteria. We also reasoned that a routine diagnostic test
requiring the use of M. bovis would be impracticable.
Kinetics of the IFN- response to M. bovis. The optimal
time after mycobacterial exposure for the measurement of
in vitro responses to antigen was assessed in two groups of
animals. In the first experiment (Fig. 2a), blood was taken
from three animals infected with M. bovis by the intranasal
route at 3, 5, 7, and 10 weeks postchallenge. The responses
were determined by measuring the percentage of CD4 T
cells producing IFN- in response to in vitro stimulation
with PPD-B (Fig. 2a). The percentage of IFN--expressing
CD4 T lymphocytes was undetectable or low at 3 weeks
postinfection (mean, 0.16%), but this was increased at week
5 (mean, 0.48%). Although there was a significant degree of
variability between animals, the trend was for increasing
numbers of CD4 cells expressing IFN- in relation to time
(Fig. 2a). A second group of seven animals (Fig. 2b) chal-
lenged with M. bovis by the intratracheal route showed sim-
ilar kinetics, with maximum numbers of IFN--secreting
cells detected 12 weeks postinfection. Significant increases
in the percentages of CD4 T cells producing IFN- in re-
FIG. 2. Kinetics of the IFN- response to M. bovis. Blood was
taken from M. bovis-infected animals at the indicated time points
postinfection and was cultured in vitro for 24 h with PPD-B. Expres-
sion of intracellular IFN- within CD4 T cells was examined by flow
cytometry. Animals were inoculated with M. bovis by the intranasal
route (a) or intratracheally (b). Data for individual animals are shown.
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sponse to in vitro stimulation with PPD-B were detected
from week 3 postinfection (P  0.01 at all time points). A
degree of animal-to-animal variation was observed; this may
reflect the extent of disease within these animals. In BCG-
vaccinated animals, responses were very low or undetect-
able, and the kinetics of the response could not be accu-
rately determined. In subsequent experiments, animals were
sampled at 12 weeks postinfection or postvaccination.
Detection of IFN- by CFC allows differentiation of cattle
infected with M. bovis from BCG vaccinates. Blood samples
from M. bovis-infected cattle, BCG-vaccinated animals, and
healthy controls were compared by CFC for numbers of CD4,
CD8, and WC1 T lymphocytes that expressed IFN- following
culture with either live BCG or PPD-B. Animals from two
experiments were studied. The initial data compared animals
infected intranasally with M. bovis (Fig. 3a); subsequently, data
were generated from animals infected intratracheally (Fig. 3b).
In each case, IFN- production was found in a higher propor-
tion of cells in M. bovis-infected animals (Fig. 3, white bars)
than in vaccinated animals (Fig. 3, black bars) in response to
both PPD and BCG. No significant responses were observed in
age-matched control calves. The differences between infected
and vaccinated groups were highly significant for CD4 cells
following culture with either PPD-B (P  0.001) or BCG
(P  0.01). Differences in IFN- expression by CD8 T cells
from infected and vaccinated animals were also evident, al-
though relatively high intra-animal variations in CD8 re-
sponses were observed, and overall, these differences were not
significant. The expression of IFN- by WC1 T cells from most
animals was low or undetectable.
Individual animals (Fig. 4) showed variable percentages of
CD4 cells expressing IFN- in response to PPD-B stimula-
tion. This was observed in animals inoculated with M. bovis
both intranasally (Fig. 4a) and intratracheally (Fig. 4b). Nev-
ertheless, the responses of M. bovis-infected animals were
largely nonoverlapping with those of BCG-vaccinated or con-
trol animals. Only one vaccinated animal showed a significant
response (Fig. 4a). The differential between vaccinated and
infected animals was most evident in the second experiment
(Fig. 4b), where all of the animals were closely age matched.
The mean (plus 2 standard deviations) was calculated for vac-
cinated animals in each experiment and determined to be 0.3
and 0.19, respectively. Using these values as a “cutoff,” 14/15
M. bovis-infected animals were determined to be infected in
the first experiment, with 1 BCG-vaccinated animal also show-
ing a significant response. In the second experiment, 7/7 in-
fected animals and 0/7 vaccinated animals were diagnosed as
being infected.
DISCUSSION
The incidence of M. bovis infections in United Kingdom
cattle herds is increasing rapidly. The failure to control the
spread of TB in cattle has many contributory factors including
FIG. 3. IFN- responses of T-lymphocyte subsets following culture
with PPD-B and BCG. Whole blood from animals infected with M.
bovis intranasally (a, n  15) or intratracheally (b, n  7), from
BCG-vaccinated animals (a, n  10; b, n  7), or from control animals
(a, n  5; b, n  6) was stimulated in vitro with PPD-B or BCG.
Intracellular IFN- expression was assessed in CD4 (white bars),
CD8 (black bars), and WC1 (gray bars)  T cells. Results are
expressed as the mean percentages of IFN--expressing T cells (CD4,
CD8, and WC1) 	 standard deviations.
FIG. 4. Expression of intracytoplasmic IFN- by CD4 T cells in
response to PPD-B discriminates M. bovis-infected animals from
BCG-vaccinated animals. Whole blood was taken and stimulated as
described in the legend of Fig. 3. Each point represents the per-
centage of CD4 cells expressing IFN- 24 h following culture with
PPD-B. Samples were assessed 12 weeks postinfection with M. bovis
via either the intranasal (a) or intratracheal (b) route or at 12 weeks
after vaccination with BCG. In each case, infected and control
animals were tested in parallel. Control animals were age-matched,
nontreated animals.
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the presence of a wildlife reservoir of disease as well as limi-
tations on the sensitivities of diagnostic tests. In addition, po-
tential strategies for the use of BCG in cattle, such as neonatal
vaccination (15, 22, 36) and heterologous prime-boost vacci-
nation (7, 23, 24, 38), are hampered by the fact that BCG-
vaccinated animals test positive by both the skin test and the
IFN- test. Differentiation of BCG-vaccinated cattle from M.
bovis-infected cattle may be achieved in assays using ESAT-6
and CFP-10 (35). However, reactivity to these antigens is not
observed in all M. bovis-infected animals (29) and is signifi-
cantly affected by prior sensitization of cattle to environmental
mycobacteria (14). There is an important requirement for the
development of sensitive diagnostic tests that can accurately
distinguish vaccinated subjects from those that are infected
with virulent mycobacteria.
The measurement of antigen-specific IFN- by CFC has
been suggested as an extremely sensitive methodology for as-
saying antigen-specific cells in PBMC and whole blood (10, 16,
17, 19–21, 28, 32–34, 39, 40). A number of studies have com-
pared CFC with other methods to detect T-cell immunity in-
cluding proliferation assays, cytotoxic-T-lymphocyte assays, major
histocompatibility complex oligomer assays, and ELISPOT (6, 17,
19, 28), and there is relatively good correlation between these
techniques. The ELISPOT technique, which detects numbers
of IFN--secreting cells, allows the estimation of the precursor
frequency of antigen-specific IFN--secreting cells and has
been suggested to accurately differentiate M. tuberculosis- or
M. bovis-infected individuals from BCG vaccinates (24, 37).
However, this is a time-consuming, and expensive, technique.
In addition, the detection of cytokine secretion by ELISPOT
reflects the balance between cytokine secretion, utilization,
and degradation and may be significantly affected by changes in
cell subset distribution.
One major advantage of CFC is that it not only allows the
enumeration of responding cells but also provides information
on the phenotypes of these cells. CFC also offers the possibility
of measuring more than one cytokine simultaneously, which
may increase the diagnostic potential. While the majority of
studies assessing the use of CFC as a diagnostic test utilized
separated PBMC, recently, Suni et al. (32) described a modi-
fication using whole blood. The results obtained with whole
blood were comparable to those observed using isolated
PBMC preparations, and it was suggested that increased fre-
quencies of responding T cells were observed in whole-blood
cultures (32). The use of whole blood reduces costs and cell
preparation time and eliminates the possibility of cell activa-
tion through separation techniques.
In this study, we described the development of bovine CFC
for the detection of mycobacterial antigen-specific IFN--se-
creting cells in whole blood. We demonstrated that M. bovis-
infected animals had significantly higher numbers of circulat-
ing antigen-specific cells than BCG-vaccinated or control
animals, detectable by CFC following in vitro stimulation of
whole blood with PPD or BCG. These results are in contrast to
those assessing the potential of CFC for the diagnosis of M.
tuberculosis infection. In a number of such studies where cells
were stimulated with PPD, it was not possible to distinguish
BCG-vaccinated patients from TB patients (1, 16, 33, 34).
Accurate diagnosis was observed only where ESAT-6 was used
as the stimulating antigen, and an overall sensitivity of between
90 and 95% was achieved. The number of responding CD4 T
cells ranged from 0.1 to approximately 1%, although overall
responses to ESAT-6 were very low (1, 16, 33, 34). Although
ESAT-6 has been suggested as a potential diagnostic tool for
distinguishing M. bovis-infected cattle from BCG-vaccinated
animals, it is clear that only a proportion of infected animals
respond to this antigen (15). In our studies, CFC of whole
blood stimulated by PPD-B gave a sensitive discrimination
between vaccinated and M. bovis-infected animals, with up-
wards of 95% animals being diagnosed positive. Only one
BCG-vaccinated animal showed a significant response using
this assay. By comparison, each of the BCG-vaccinated animals
showed strong IFN- secretion by ELISA (data not shown),
and we have previously shown that although BCG vaccination
induced lower skin test reactivity than M. bovis infection, all
BCG vaccinates scored positive by this test (15). This suggests
that CFC could be a sensitive method for differential diagnosis.
Another important consideration is the ability to accurately
distinguish those vaccinated animals that are protected from
M. bovis infection from vaccinated animals that will go on to
develop disease. It is clear from a number of studies that
although on a group/herd basis, BCG has the potential to
induce a significant level of protection, some animals still show
evidence of disease, and these animals could be a potential
source of cattle-to-cattle transmission of M. bovis. Accurate
identification of such animals would be essential for the overall
success of BCG vaccination strategies in the field. Early indi-
cations from this laboratory suggest that CFC using PPD-B can
accurately detect BCG-vaccinated animals that are infected
with M. bovis, although at present, only low numbers of such
animals have been assessed, and studies are ongoing. These
data suggest that this method could accurately diagnose M.
bovis-infected cattle in the field.
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